financetom
Business
financetom
/
Business
/
Update: Proto Labs Shares Fall After Q4 Non-GAAP Net Income, Revenue Decline
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Update: Proto Labs Shares Fall After Q4 Non-GAAP Net Income, Revenue Decline
Feb 7, 2025 7:35 AM

10:04 AM EST, 02/07/2025 (MT Newswires) -- (Updates with the latest stock movement in the headline and first paragraph and additional detail in the last paragraph.)

Proto Labs ( PRLB ) shares were down 1.1% in recent Friday trading after the company reported lower Q4 results.

The company earlier reported Q4 non-GAAP net income of $0.38 per diluted share, down from $0.46 a year earlier.

Analysts polled by FactSet expected $0.32.

Revenue for the quarter ended Dec. 31 was $121.8 million, down from $125.0 million a year earlier.

Analysts surveyed by FactSet expected $120.2 million.

For Q1, the digital manufacturing services provider expects non-GAAP diluted net income per share between $0.26 and $0.34 on revenue of $120 million to $128 million. Analysts polled by FactSet expect non-GAAP EPS of $0.34 on revenue of $124.5 million.

The company also said its board on Tuesday also approved a $100 million open-ended share repurchase program.

Price: 43.89, Change: -0.50, Percent Change: -1.13

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
BRIEF-Suke Files For U.S. IPO Of Up To 2.0 Million Ordinary Shares - SEC Filing
BRIEF-Suke Files For U.S. IPO Of Up To 2.0 Million Ordinary Shares - SEC Filing
Mar 12, 2024
March 12 (Reuters) - * SUKE LTD FILES FOR U.S. IPO OF UP TO 2.0 MILLION ORDINARY SHARES - SEC FILING * SUKE LTD SAYS ANTICIPATES IPO PRICE PER ORDINARY SHARE WILL BE BETWEEN $4.00 AND $6.00 * SUKE LTD SAYS IN ADDITION, 1.75 MILLION ORDINARY SHARES WILL BE OFFERED FOR POTENTIAL RESALE BY SELLING SHAREHOLDERS * SUKE LTD SAYS...
Incyte's Povorcitinib Potentially Suited for Hidradenitis Suppurativa, Prurigo Nodularis, RBC Says
Incyte's Povorcitinib Potentially Suited for Hidradenitis Suppurativa, Prurigo Nodularis, RBC Says
Mar 12, 2024
04:53 PM EDT, 03/12/2024 (MT Newswires) -- Incyte's ( INCY ) povorcitinib has the potential to treat patients with hidradenitis suppurativa and prurigo nodularis, while opzelura is less likely to be used for mild hidradenitis suppurativa, RBC Capital Markets said in an emailed Tuesday. Hidradenitis suppurativa and prurigo nodularis are both skin conditions. The latest phase 2 data of povorcitinib...
--Agree Realty Keeps Monthly Dividend at $0.247 a Share, Payable April 12 to Holders of Record March 28
--Agree Realty Keeps Monthly Dividend at $0.247 a Share, Payable April 12 to Holders of Record March 28
Mar 12, 2024
04:51 PM EDT, 03/12/2024 (MT Newswires) -- Price: 57.82, Change: +0.6, Percent Change: +1.05 ...
Skechers Usa Insider Sold Shares Worth $5,514,943, According to a Recent SEC Filing
Skechers Usa Insider Sold Shares Worth $5,514,943, According to a Recent SEC Filing
Mar 12, 2024
04:50 PM EDT, 03/12/2024 (MT Newswires) -- Michael Greenberg, Director, President, on March 11, 2024, sold 91,500 shares in Skechers Usa ( SKX ) for $5,514,943. Following the Form 4 filing with the SEC, Greenberg has control over a total of 123,441 shares of the company, with 123,441 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1065837/000120919124004780/xslF345X03/doc4.xml ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved